Compare IQV & AZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | AZO |
|---|---|---|
| Founded | 1982 | 1979 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Auto & Home Supply Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.1B | 49.5B |
| IPO Year | 2013 | 1999 |
| Metric | IQV | AZO |
|---|---|---|
| Price | $264.36 | $3,306.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 27 |
| Target Price | $311.89 | ★ $3,665.61 |
| AVG Volume (30 Days) | ★ 1.2M | 156.3K |
| Earning Date | 10-27-2026 | 12-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.67 | ★ 5.30 |
| EPS | 5.24 | ★ 152.55 |
| Revenue | $9,739,000,000.00 | ★ $20,338,555,000.00 |
| Revenue This Year | $7.18 | $7.29 |
| Revenue Next Year | $6.34 | $7.03 |
| P/E Ratio | $50.37 | ★ $21.82 |
| Revenue Growth | ★ 41.60 | 7.39 |
| 52 Week Low | $154.50 | $2,730.65 |
| 52 Week High | $284.50 | $3,996.25 |
| Indicator | IQV | AZO |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 67.68 |
| Support Level | $252.55 | $3,293.88 |
| Resistance Level | $276.99 | $3,537.44 |
| Average True Range (ATR) | 10.38 | 76.20 |
| MACD | -1.50 | 12.50 |
| Stochastic Oscillator | 35.53 | 92.19 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Founded in 1979, AutoZone is the largest US-based retailer of aftermarket automotive parts and accessories, operating over 7,600 stores and generating over $20 billion in fiscal 2026 sales. Beyond its primary home market (86% of total revenue), the company also maintains a growing presence in Mexico and Brazil. AutoZone caters to two core customer segments: do-it-yourself, which account for roughly two-thirds of its domestic sales, and commercial do-it-for-me customers, which represent the remainder.